Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease

Christine M. Eng, Nathalie Guffon, William R. Wilcox, Dominique P. Germain, Philip Lee, Steve Waldek, Louis Caplan, Garbor E. Linthorst, Robert J. Desnick

Research output: Contribution to journalArticlepeer-review

1389 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences